Zuclopenthixol,53772-83-1

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Zuclopenthixol

CAS No. : 53772-83-1

MCE 国际站：Zuclopenthixol

产品活性：Zuclopenthixol 是一种噻吨衍生物，它是多巴胺D1/D2受体 (dopamine D1/D2 receptor) 的拮抗剂。

研究领域：GPCR/G Protein  |  Neuronal Signaling

作用靶点：Dopamine Receptor

In Vivo: After acute treatment, Zuclopenthixol (0.2 and 0.4 mg/kg)-treated animals exhibit ethopharmacological profiles characterized by a decrease in offensive behaviors without impairment of motor activity (0.2 mg/kg). In contrast, the antiaggressive action of the highest dose used (0.4 mg/kg) is accompanied by a marked increase of immobility. After subchronic treatment, no tolerance to Zuclopenthixol antiaggressive or motor activity is observed.
Administration of Zuclopenthixol (0.7 and 1.4 mg/kg) significantly elevate MDA level compared to respective controls. Nevertheless, there is no difference between the two dose levels with respect to their effect on rat brain MDA level. Post hoc pairwise comparisons between the means of groups (n=12) receiving different dose levels of Zuclopenthixol reveal that administration of 1.4 mg/kg of Zuclopenthixol significantly reduces GSH level compared to both vehicle-treated and Zuclopenthixol (0.7 mg/kg)-treated animals (P<0.001). Nevertheless, the lower dose of the drug does not affect rat brain GSH level. Animals receiving 0.7 or 1.4 mg/kg of Zuclopenthixol exhibits significantly higher GSH levels than SCO treated animals. Administration of 0.7 mg/kg of Zuclopenthixol significantly elevated GSHPx activity compared to vehicle treated animals.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Neuronal Signaling Compound Library  |  FDA-Approved Drug Library  |  Drug Repurposing Compound Library  |  Anti-COVID-19 Compound Library  |  Orally Active Compound Library  |  Neurotransmitter Receptor Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Neurodegenerative Disease-related Compound Library  |  Human Metabolite Library  |  Off-patent Drug Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Dopamine Receptor Compound Library  |  Clozapine N-oxide  |  MPTP hydrochloride  |  Oxidopamine hydrobromide  |  Chlorpromazine hydrochloride  |  L-DOPA  |  Dopamine hydrochloride  |  SCH-23390 hydrochloride  |  Haloperidol  |  SKF 38393 hydrochloride  |  Pimozide  |  Cabergoline  |  Bromocriptine mesylate  |  Risperidone  |  Olanzapine  |  Thioridazine hydrochloride  |  Brexpiprazole  |  Aripiprazole  |  Fluphenazine dihydrochloride  |  Sulpiride  |  Flunarizine dihydrochloride  |  ONC206  |  WAY-100635 maleate  |  Quetiapine  |  Trifluoperazine dihydrochloride  |  Lurasidone  |  Nuciferine

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds